Human chorionic gonadotropin (hCG): Clinical Trials

4 trials of Human chorionic gonadotropin (hCG), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 1, Withdrawn 1

Follow Human chorionic gonadotropin (hCG): new trials by email Literature Review of Human chorionic gonadotropin (hCG) trials Research Report on Human chorionic gonadotropin (hCG)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)
Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response
Phase 3RecruitingFundación para la Investigación del Hospital Clínico de Valencia1262024-09-172026-09-11
An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)
MK-8962, recFSH, Ganirelix - Infertility
Phase 3WithdrawnOrganon and Co2014-03-012022-02-03
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
COL-1620, Gonadotropin-releasing hormone (GnRH) analogue, Follicle-stimulating hormone (FSH) - Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer
Phase 3CompletedMerck KGaA, Darmstadt, Germany1782013-07-012015-12-21
A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
Recombinant human luteinizing hormone (r-hLH), Recombinant human follicle-stimulating hormone (r-hFSH), Human chorionic gonadotropin (hCG) - Hypogonadism
Phase 3CompletedMerck KGaA, Darmstadt, Germany312004-02-012013-12-27

Conditions studied

Infertility (2)  ·  Hypogonadism (1)

Sponsors

Merck KGaA, Darmstadt, Germany (2)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Organon and Co (1)

Countries

China (1)  ·  Japan (1)  ·  Spain (1)

Top investigators

Cesar Lizan Tudela (1)  ·  Xin Li (1)